GLENMARK THERAPEUTICS
Live / Registered — Registered (as of 27 Feb 2024)
What this means for you
Registered since 27 Feb 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Feb 2030: the §8 declaration of use).
Record
- Serial number
- 97976501
- Registration number
- 7317749
- Mark type
- Word mark
- Filed
- 04 Apr 2022
- Published for opposition
- 20 Sept 2022
- Registered
- 27 Feb 2024
- Next maintenance filing
- §8 declaration of use, due by 27 Feb 2030 (grace period to 27 Aug 2030)
- Attorney of record
- Maxim A. Voltchenko
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, antacids, acid reducers for the management of heartburn
Owner
- Glenmark Therapeutics Inc., USA, Mahwah, NJ, US
- Glenmark Therapeutics Inc., USA, Mahwah, NJ, US
- Glenmark Therapeutics Inc., USA, Mahwah, NJ, US
Prior registrations
Prosecution history
- 19 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Dec 2023 — NON-FINAL ACTION E-MAILED
- 15 Dec 2023 — SU - NON-FINAL ACTION - WRITTEN
- 18 Sept 2023 — DIVISIONAL PROCESSING COMPLETE
- 03 May 2023 — DIVISIONAL REQUEST RECEIVED
- 31 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL